胸段硬膜外镇痛与胰腺手术后生存改善无关:PAKMAN随机对照试验长期随访
PAKMAN试验的长期随访比较胰腺部分切除术后胸段硬膜外镇痛(EDA)与患者自控静脉镇痛(PCIA)对生存的影响。结论不支持在胰腺手术中优先选择EDA而非PCIA。
要点
- 胰腺手术后EDA与PCIA的总生存和无复发生存无显著差异。
- 仅恶性肿瘤患者亚组中EDA与PCIA总生存也无显著差异。
- 两组长期生活质量和疼痛严重程度影响相似。
核心结论
- PAKMAN试验长期随访结果不支持在胰腺手术中优先选择胸段硬膜外镇痛而非PCIA。
- 在获得进一步证据前,EDA与PCIA应被视为对长期生存影响相似。
研究设计与样本
- PAKMAN试验为适应性、实用性、国际、多中心、随机对照优效性试验,于2015年6月至2017年10月进行。
- 长期随访于2020年10月至2021年4月(指数手术后3至5年)进行。
- 生存长期随访纳入109例EDA患者与111例PCIA患者,均为部分胰十二指肠切除术后。
- 生活质量与疼痛评估长期随访纳入40例EDA患者与45例PCIA患者(问卷应答率94%)。
主要发现
- 两组长期生活质量与疼痛严重程度影响相似(EDA:n=40,PCIA:n=45)。
临床怎么用
- 胰腺手术术后镇痛选择中,不应以改善长期生存为由优先选择EDA而非PCIA。
- EDA与PCIA在长期生存、生活质量和疼痛控制方面可视为相似选项。
局限性
- 生活质量与疼痛评估的长期随访样本量较小(EDA 40例,PCIA 45例)。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative thoracic epidural analgesia (EDA) and patient-controlled intravenous analgesia (PCIA) are common forms of analgesia after pancreatic surgery. Current guidelines recommend EDA over PCIA, and evidence suggests that EDA may improve long-term survival after surgery, especially in cancer patients. The aim of this study was to determine whether perioperative EDA is associated with an improved patient prognosis compared to PCIA in pancreatic surgery. METHODS: The PAKMAN trial was an adaptive, pragmatic, international, multicenter, randomized controlled superiority trial conducted from June 2015 to October 2017. Three to five years after index surgery a long-term follow-up was performed from October 2020 to April 2021. RESULTS: For long-term follow-up of survival, 109 patients with EDA were compared to 111 patients with PCIA after partial pancreatoduodenectomy (PD). Long-term follow-up of quality of life (QoL) and pain assessment was available for 40 patients with EDA and 45 patients with PCIA (questionnaire response rate: 94%). Survival analysis revealed that EDA, when compared to PCIA, was not associated with improved overall survival (OS, HR, 1.176, 95% HR-CI, 0.809-1.710, P = .397, n = 220). Likewise, recurrence-free survival did not differ between groups (HR, 1.116, 95% HR-CI, 0.817-1.664, P = .397, n = 220). OS subgroup analysis including only patients with malignancies showed no significant difference between EDA and PCIA (HR, 1.369, 95% HR-CI, 0.932-2.011, P = .109, n = 179). Similar long-term effects on QoL and pain severity were observed in both groups (EDA: n = 40, PCIA: n = 45). CONCLUSIONS: Results from this long-term follow-up of the PAKMAN randomized controlled trial do not support favoring EDA over PCIA in pancreatic surgery. Until further evidence is available, EDA and PCIA should be considered similar regarding long-term survival.
引用
- Klotz R, Ahmed A, Tremmel A, et al. Thoracic Epidural Analgesia Is Not Associated With Improved Survival After Pancreatic Surgery: Long-Term Follow-Up of the Randomized Controlled PAKMAN Trial. Anesth Analg. 2025. PMID: 38335141. doi:10.1213/ANE.0000000000006812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。